You are here

New Insights Into Conquering Influenza

Protein protects against viral infections, including the flu (Jan. 29)

Australian researchers at the University of Melbourne and the Walter and Eliza Hall Institute have discovered a new protein that protects against viral infections, such as influenza.

The investigators believe they have a new clue to why some people fight infections better than others. They have been investigating the “defensive devices” contained in the T-cells located on exposed body surfaces, such as skin and mucosal surfaces, to ward off infection. T-cells detect cells infected with viruses and kill them before the virus can reproduce within the infected cell and spread to other cells.

The researchers found that the T-cells contain the protein IFITM3, and that this makes them more resistant to viral infections, such as influenza. The new findings were published in Nature Immunology.

“If we learn how to increase the number and longevity of T-cells expressing IFITM3, this could lead to improved vaccines that promote the generation of more resistant T-cells able to provide the greatest protection, for longer,” said Professor José Villadangos.

Co-investigator Dr. Linda Wakim commented: “We are currently trying to understand why some T-cells and not others express this protective molecule. Probably they encounter some form of chemical signal — a cytokine or a surface molecule — in the tissues where they lodge, which induces the expression of IFITM3. If we identify these chemical cues, we may be able to include them in future vaccines.”

Source: University of Melbourne; January 29, 2013.

Recent Headlines

Despite older, sicker patients, mortality rate fell by a third in 10 years
Study finds fewer than half of trials followed the law
WHO to meet tomorrow to decide on international public heath emergency declaration
Study of posted prices finds wild variations and missing data
Potential contamination could lead to supply chain disruptions
Mortality nearly doubled when patients stopped using their drugs
Acasti reports disappointing results for a second Omega-3-based drug
Declining lung cancer mortality helped fuel the progress
Kinase inhibitor targets tumors with a PDGFRA exon 18 mutation